{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T09:27:38Z","timestamp":1794302858454,"version":"4.9.0"},"reference-count":159,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ajo.2026.09.019","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:19:26Z","timestamp":1789665566000},"page":"683-704","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Regeneration and Replacement of the Corneal Endothelium: Advances in Cell Therapy, Tissue Engineering, Molecular and Pharmacologic Strategies"],"prefix":"10.1016","volume":"292","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8619-1490","authenticated-orcid":false,"given":"STEPHAN","family":"ONG\u202f\u202fTONE","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AE RA","family":"KEE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2989-1482","authenticated-orcid":false,"given":"WANG","family":"WEILIANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JIANG","family":"DAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4661-0993","authenticated-orcid":false,"given":"MICHAEL","family":"MIMOUNI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ULA","family":"JURKUNAS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6839-251X","authenticated-orcid":false,"given":"SHIGERU","family":"KINOSHITA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JODHBIR","family":"MEHTA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ajo.2026.09.019_bib0001","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/jamaophthalmol.2015.4776","article-title":"Global Survey of corneal transplantation and eye banking","volume":"134","author":"Gain","year":"2016","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2026.09.019_bib0002","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ajpath.2012.03.033","article-title":"ROCK inhibitor converts corneal endothelial cells into a phenotype capable of regenerating in vivo endothelial tissue","volume":"181","author":"Okumura","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajo.2026.09.019_bib0003","doi-asserted-by":"crossref","DOI":"10.1038\/srep26113","article-title":"Rho kinase inhibitor enables cell-based therapy for corneal endothelial dysfunction","volume":"6","author":"Okumura","year":"2016","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.ajo.2026.09.019_bib0004","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1056\/NEJMoa1712770","article-title":"Injection of cultured cells with a ROCK inhibitor for bullous keratopathy","volume":"378","author":"Kinoshita","year":"2018","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ajo.2026.09.019_bib0005","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ophtha.2020.09.002","article-title":"Five-year follow-up of first 11 patients undergoing injection of cultured corneal endothelial cells for corneal endothelial failure","volume":"128","author":"Numa","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2026.09.019_bib0006","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ajo.2021.11.012","article-title":"Superiority of mature differentiated cultured Human corneal endothelial cell injection therapy for corneal endothelial failure","volume":"237","author":"Ueno","year":"2022","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"10.1016\/j.ajo.2026.09.019_bib0007","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.ophtha.2025.05.020","article-title":"Long-term corneal rejuvenation after transplantation of cultured Human corneal endothelial cells","volume":"132","author":"Kinoshita","year":"2025","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ajo.2026.09.019_bib0008","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1167\/iovs.16-20703","article-title":"Production of homogeneous cultured human corneal endothelial cells indispensable for innovative cell therapy","volume":"58","author":"Toda","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"10.1016\/j.ajo.2026.09.019_bib0009","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1089\/jop.2023.0044","article-title":"Development of anterior segment focused biologic therapies to regenerate corneal tissue for the treatment of disease: drug development experience","volume":"39","author":"Rowe-Rendleman","year":"2023","journal-title":"J Ocul Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.ajo.2026.09.019_bib0010","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s10384-024-01123-w","article-title":"Comprehensive combined analysis of physician-initiated phase ii and iii clinical trials on a cultured human corneal endothelial cell product for treating bullous keratopathy","volume":"68","author":"Ueno","year":"2024","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.ajo.2026.09.019_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.ophtha.2026.08.007","article-title":"Endothelial cell therapy for post-keratoplasty corneal endothelial failure","author":"Kataoka","year":"2026","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.ajo.2026.09.019_bib0012","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1097\/ICO.0000000000003844","article-title":"ESCAL\u00d3N: a prospective randomized trial of corneal endothelial cell therapy in subjects with corneal edema","volume":"44","author":"Holland","year":"2025","journal-title":"Cornea"},{"key":"10.1016\/j.ajo.2026.09.019_bib0013","unstructured":"Study Details NCT06041256 | A phase 1\/2 study of AURN001 in subjects with corneal edema secondary to corneal endothelial dysfunction (ABA-1) | clinical trials. ClinicalTrials.gov. Accessed September 8, 2026. https:\/\/clinicaltrials.gov\/study\/NCT06041256."},{"key":"10.1016\/j.ajo.2026.09.019_bib0014","unstructured":"Study Details NCT07368959 | AURN001 Efficacy in participants with corneal edema secondary to corneal endothelial dysfunction | clinical trials. ClinicalTrials.gov. Accessed September 8, 2026. https:\/\/clinicaltrials.gov\/study\/NCT07368959."},{"issue":"7","key":"10.1016\/j.ajo.2026.09.019_bib0015","first-page":"5784","article-title":"A phase 1, multicenter study of magnetic human endothelial cell therapy for corneal edema","volume":"65","author":"Chamberlain","year":"2024","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.ajo.2026.09.019_bib0016","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0014-4835(03)00057-5","article-title":"Magnetic attraction of iron-endocytosed corneal endothelial cells to Descemet\u2019s membrane","volume":"76","author":"Mimura","year":"2003","journal-title":"Exp Eye Res"},{"issue":"2","key":"10.1016\/j.ajo.2026.09.019_bib0017","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.exer.2004.08.021","article-title":"Long-term outcome of iron-endocytosing cultured corneal endothelial cell transplantation with magnetic attraction","volume":"80","author":"Mimura","year":"2005","journal-title":"Exp Eye Res"},{"issue":"3","key":"10.1016\/j.ajo.2026.09.019_bib0018","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.nano.2014.12.002","article-title":"Magnetic field-guided cell delivery with nanoparticle-loaded human corneal endothelial cells","volume":"11","author":"Moysidis","year":"2015","journal-title":"Nanomedicine"},{"issue":"7","key":"10.1016\/j.ajo.2026.09.019_bib0019","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1167\/iovs.18-26001","article-title":"Magnetic Human corneal endothelial cell transplant: delivery, retention, and short-term efficacy","volume":"60","author":"Xia","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"19","key":"10.1016\/j.ajo.2026.09.019_bib0020","doi-asserted-by":"crossref","DOI":"10.3390\/polym13193306","article-title":"Effects of electromagnets on bovine corneal endothelial cells treated with dendrimer functionalized magnetic nanoparticles","volume":"13","author":"Hatamie","year":"2021","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.ajo.2026.09.019_bib0021","unstructured":"Joyce NC, Harris DL, Mello DM. Mechanisms of mitotic inhibition in corneal endothelium: contact inhibition and TGF-beta2. Invest Ophthalmol Vis Sci. 2002;43(7):2152-2159. Accessed September 8, 2026. https:\/\/pubmed.ncbi.nlm.nih.gov\/12091410\/."},{"issue":"6","key":"10.1016\/j.ajo.2026.09.019_bib0022","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.exer.2005.06.012","article-title":"Cell cycle status in human corneal endothelium","volume":"81","author":"Joyce","year":"2005","journal-title":"Exp Eye Res"},{"issue":"1","key":"10.1016\/j.ajo.2026.09.019_bib0023","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.exer.2011.08.014","article-title":"Proliferative capacity of corneal endothelial cells","volume":"95","author":"Joyce","year":"2012","journal-title":"Exp Eye Res"},{"issue":"4","key":"10.1016\/j.ajo.2026.09.019_bib0024","doi-asserted-by":"crossref","DOI":"10.1167\/iovs.62.4.8","article-title":"Interleukin-1 and transforming growth factor Beta: commonly opposing, but sometimes supporting, master regulators of the corneal wound healing response to injury","volume":"62","author":"Wilson","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"15","key":"10.1016\/j.ajo.2026.09.019_bib0025","doi-asserted-by":"crossref","DOI":"10.3390\/cells11152336","article-title":"TGF-\u03b2 superfamily signaling in the eye: implications for ocular pathologies","volume":"11","author":"Hachana","year":"2022","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.ajo.2026.09.019_bib0026","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3727\/096368913X664559","article-title":"Factors affecting successful isolation of human corneal endothelial cells for clinical use","volume":"23","author":"Choi","year":"2014","journal-title":"Cell Transplant"},{"issue":"7","key":"10.1016\/j.ajo.2026.09.019_bib0027","first-page":"611","article-title":"Enhanced survival in vitro of human corneal endothelial cells using mouse embryonic stem cell conditioned medium","volume":"16","author":"Lu","year":"2010","journal-title":"Mol Vis"},{"issue":"7","key":"10.1016\/j.ajo.2026.09.019_bib0028","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069009","article-title":"Corneal endothelial expansion promoted by human bone marrow mesenchymal stem cell-derived conditioned medium","volume":"8","author":"Nakahara","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ajo.2026.09.019_bib0029","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3727\/096368913X675719","article-title":"Propagation of human corneal endothelial cells: a novel dual media approach","volume":"24","author":"Peh","year":"2015","journal-title":"Cell Transplant"},{"key":"10.1016\/j.ajo.2026.09.019_bib0030","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.exer.2014.04.002","article-title":"Effect of amniotic fluid on the invitro culture of human corneal endothelial cells","volume":"122","author":"Feizi","year":"2014","journal-title":"Exp Eye Res"},{"issue":"12","key":"10.1016\/j.ajo.2026.09.019_bib0031","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028310","article-title":"Cultivation of human corneal endothelial cells isolated from paired donor corneas","volume":"6","author":"Peh","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ajo.2026.09.019_bib0032","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/bjophthalmol-2014-306034","article-title":"Use of human serum for human corneal endothelial cell culture","volume":"99","author":"Vianna","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2026.09.019_bib0033","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.exer.2013.08.008","article-title":"Human amniotic epithelial cell niche enhances the functional properties of human corneal endothelial cells via inhibiting p53-survivin-mitochondria axis","volume":"116","author":"Sha","year":"2013","journal-title":"Exp Eye Res"},{"issue":"1","key":"10.1016\/j.ajo.2026.09.019_bib0034","article-title":"A first-in-human clinical study of an allogenic iPSC-derived corneal endothelial cell substitute transplantation for bullous keratopathy","volume":"6","author":"Hirayama","year":"2025","journal-title":"Cell Rep Med"},{"issue":"1","key":"10.1016\/j.ajo.2026.09.019_bib0035","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0014-4835(79)90164-7","article-title":"Origins of avian ocular and periocular tissues","volume":"29","author":"Johnston","year":"1979","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.ajo.2026.09.019_bib0036","first-page":"11","article-title":"Construction of tissue engineered cornea with skin-derived corneal endothelial-like cell and mechanism research for the cell differentiation","author":"Shen","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.ajo.2026.09.019_bib0037","doi-asserted-by":"crossref","DOI":"10.1017\/erm.2015.16","article-title":"Dental stem cells: a future asset of ocular cell therapy","volume":"17","author":"Yam","year":"2015","journal-title":"Expert Rev Mol Med"},{"issue":"6","key":"10.1016\/j.ajo.2026.09.019_bib0038","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cells9061428","article-title":"A novel approach of harvesting viable single cells from donor corneal endothelium for cell-injection therapy","volume":"9","author":"Ong","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ajo.2026.09.019_bib0039","unstructured":"Study Details NCT07711561 | Simple non-cultured endothelial cell therapy for corneal endothelial dysfunction | clinical trials. ClinicalTrials.gov. Accessed September 8, 2026. https:\/\/clinicaltrials.gov\/study\/NCT07711561."},{"issue":"18","key":"10.1016\/j.ajo.2026.09.019_bib0040","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1089\/ars.2015.6532","article-title":"Menadione-induced DNA damage leads to mitochondrial dysfunction and fragmentation during rosette formation in Fuchs endothelial corneal dystrophy","volume":"24","author":"Halilovic","year":"2016","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"10.1016\/j.ajo.2026.09.019_bib0041","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-30383-8","article-title":"Rescuing cellular function in fuchs endothelial corneal dystrophy by healthy exogenous mitochondrial internalization","volume":"13","author":"M\u00e9thot","year":"2023","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.ajo.2026.09.019_bib0042","doi-asserted-by":"crossref","DOI":"10.3390\/cells10081888","article-title":"Mitochondrial dysfunction and mitophagy in Fuchs endothelial corneal dystrophy","volume":"10","author":"Kumar","year":"2021","journal-title":"Cells."},{"issue":"11","key":"10.1016\/j.ajo.2026.09.019_bib0043","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.358","article-title":"Mitochondrial transfer of mesenchymal stem cells effectively protects corneal epithelial cells from mitochondrial damage","volume":"7","author":"Jiang","year":"2016","journal-title":"Cell Death Dis"},{"issue":"16","key":"10.1016\/j.ajo.2026.09.019_bib0044","doi-asserted-by":"crossref","first-page":"7260","DOI":"10.7150\/thno.46332","article-title":"Bioenergetic crosstalk between mesenchymal stem cells and various ocular cells through the intercellular trafficking of mitochondria","volume":"10","author":"Jiang","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.ajo.2026.09.019_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.mito.2025.102042","article-title":"Mitochondrial transplantation: triumphs, challenges, and impacts on nuclear genome remodelling","volume":"84","author":"Shin","year":"2025","journal-title":"Mitochondrion"},{"issue":"10","key":"10.1016\/j.ajo.2026.09.019_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2026.02.023","article-title":"Transplantation of encapsulated mitochondria alleviates dysfunction in mitochondrial and Parkinson\u2019s disease models","volume":"189","author":"Du","year":"2026","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.ajo.2026.09.019_bib0047","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics18020186","article-title":"Corneal extracellular vesicles: small packages with a big impact","volume":"18","author":"Hefley","year":"2026","journal-title":"Pharmaceutics"},{"issue":"13","key":"10.1016\/j.ajo.2026.09.019_bib0048","doi-asserted-by":"crossref","DOI":"10.1167\/iovs.64.13.29","article-title":"Adipose mesenchymal stem cell-derived exosomes promote the regeneration of corneal endothelium through ameliorating senescence","volume":"64","author":"Ryu","year":"2023","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"10.1016\/j.ajo.2026.09.019_bib0049","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.3390\/ijms22094930","article-title":"Mesenchymal stem cell-derived extracellular vesicles protect human corneal endothelial cells from endoplasmic reticulum stress-mediated apoptosis","volume":"22","author":"Buono","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajo.2026.09.019_bib0050","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6644463","article-title":"Effect of stem cell-derived extracellular vesicles on damaged human corneal endothelial cells","volume":"2021","author":"Nuzzi","year":"2021","journal-title":"Stem Cells Int"},{"issue":"5","key":"10.1016\/j.ajo.2026.09.019_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e26800","article-title":"EGF-conditioned M1 macrophages convey reduced inflammation into corneal endothelial cells through exosomes","volume":"10","author":"Lee","year":"2024","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.ajo.2026.09.019_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2025.100900","article-title":"Small extracellular vesicle\u2013mediated peptide delivery to the mouse corneal endothelium in vivo","volume":"6","author":"Lee","year":"2026","journal-title":"Ophthalmol Sci"},{"issue":"4","key":"10.1016\/j.ajo.2026.09.019_bib0053","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2022.100212","article-title":"Cellular interplay through extracellular vesicle miR-184 alleviates corneal endothelium degeneration","volume":"2","author":"Yamashita","year":"2022","journal-title":"Ophthalmol Sci"},{"issue":"14","key":"10.1016\/j.ajo.2026.09.019_bib0054","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241411490","article-title":"Inhibiting miR-195-5p induces proliferation of human corneal endothelial cells","volume":"24","author":"Parekh","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajo.2026.09.019_bib0055","article-title":"Extracellular vesicles derived from human corneal endothelial cells inhibit proliferation of human corneal endothelial cells","volume":"8","author":"Parekh","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"13","key":"10.1016\/j.ajo.2026.09.019_bib0056","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1016\/j.biomaterials.2014.01.033","article-title":"Heparin-modified gelatin scaffolds for human corneal endothelial cell transplantation","volume":"35","author":"Niu","year":"2014","journal-title":"Biomaterials"},{"issue":"9","key":"10.1016\/j.ajo.2026.09.019_bib0057","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1167\/iovs.03-1174","article-title":"Cultured human corneal endothelial cell transplantation with a collagen sheet in a rabbit model","volume":"45","author":"Mimura","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.ajo.2026.09.019_bib0058","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3109\/02713683.2011.644382","article-title":"Decellularized bovine corneal posterior lamellae as carrier matrix for cultivated human corneal endothelial cells","volume":"37","author":"Bayyoud","year":"2012","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.ajo.2026.09.019_bib0059","article-title":"Fabrication of bioengineered corneal endothelial grafts using an allogeneic cornea-derived matrix","volume":"25","author":"Xie","year":"2024","journal-title":"Mater Today Bio"},{"key":"10.1016\/j.ajo.2026.09.019_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.108125","article-title":"Evaluation of reconstructed human corneal endothelium sheets made with porcine descemet\u2019s membrane in vitro and in vivo","volume":"197","author":"Lu","year":"2020","journal-title":"Exp Eye Res"},{"issue":"8","key":"10.1016\/j.ajo.2026.09.019_bib0061","first-page":"1026","article-title":"Precise-Bio\u2019s PVEK implant for treatment of corneal endothelial dysfunction","volume":"66","author":"Belmaker","year":"2025","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2026.09.019_bib0062","unstructured":"Study Details NCT07325097 | PVEK corneal implant for treatment of corneal edema | clinical trials. ClinicalTrials.gov. Accessed September 8, 2026. https:\/\/clinicaltrials.gov\/study\/NCT07325097."},{"key":"10.1016\/j.ajo.2026.09.019_bib0063","series-title":"ASCRS Annual Meeting","article-title":"Initial experience with first-in-human bioengineered corneal endothelial implantation (PVEK)","author":"Mimouni","year":"2026"},{"issue":"6","key":"10.1016\/j.ajo.2026.09.019_bib0064","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/hmg\/ddy018","article-title":"Oligonucleotides targeting TCF4 triplet repeat expansion inhibit RNA Foci and mis-splicing in Fuchs\u2019 dystrophy","volume":"27","author":"Hu","year":"2018","journal-title":"Hum Mol Genet"},{"issue":"4","key":"10.1016\/j.ajo.2026.09.019_bib0065","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ajhg.2018.02.010","article-title":"Antisense therapy for a common corneal dystrophy ameliorates TCF4 repeat expansion-mediated toxicity","volume":"102","author":"Zarouchlioti","year":"2018","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ajo.2026.09.019_bib0066","first-page":"95","article-title":"Biallelic rescue of CTG18.1 in two Fuchs endothelial corneal dystrophy\u2013derived iPSC lines (SCTCi047-A-2, SCTCi046-A-2) following a two-step gene editing strategy","author":"Landi","year":"2026","journal-title":"Stem Cell Res"},{"issue":"9","key":"10.1016\/j.ajo.2026.09.019_bib0067","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1167\/tvst.9.9.47","article-title":"Trinucleotide repeat-targeting dCas9 as a therapeutic strategy for Fuchs\u2019 endothelial corneal dystrophy","volume":"9","author":"Rong","year":"2020","journal-title":"Transl Vis Sci Technol."},{"issue":"8","key":"10.1016\/j.ajo.2026.09.019_bib0068","first-page":"1333","article-title":"Pharmacological and molecular features of DT-168, a topical GeneTACTM small molecule being developed as potential treatment for Fuchs endothelial corneal dystrophy caused by CTG repeat expansions in the TCF4 gene","volume":"64","author":"Powers","year":"2023","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2026.09.019_bib0069","unstructured":"Study Details NCT07024693 | DT-168 in keratoplasty patients with fuchs endothelial corneal dystrophy | ClinicalTrials.Gov. Accessed September 8, 2026. https:\/\/clinicaltrials.gov\/study\/NCT07024693."},{"key":"10.1016\/j.ajo.2026.09.019_bib0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100863","article-title":"Fuchs endothelial corneal dystrophy: the vicious cycle of fuchs pathogenesis","volume":"80","author":"Ong Tone","year":"2021","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"10.1016\/j.ajo.2026.09.019_bib0071","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/08820538.2022.2112698","article-title":"Rho-kinase inhibitors: role in corneal endothelial disorders","volume":"38","author":"Singh","year":"2023","journal-title":"Semin Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2026.09.019_bib0072","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/ICU.0000000000000748","article-title":"Rho kinase (ROCK) inhibitors in the management of corneal endothelial disease","volume":"32","author":"Syed","year":"2021","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.ajo.2026.09.019_bib0073","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2147\/DDDT.S435522","article-title":"The role of rho kinase inhibitors in corneal diseases","volume":"18","author":"Futterknecht","year":"2024","journal-title":"Drug Des Devel Ther."},{"issue":"7","key":"10.1016\/j.ajo.2026.09.019_bib0074","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1136\/bjo.2010.194571","article-title":"Enhancement of corneal endothelium wound healing by rho-associated kinase (ROCK) inhibitor eye drops","volume":"95","author":"Okumura","year":"2011","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2026.09.019_bib0075","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1097\/ICO.0b013e318285475d","article-title":"Rho-associated kinase inhibitor eye drop treatment as a possible medical treatment for Fuchs corneal dystrophy","volume":"32","author":"Koizumi","year":"2013","journal-title":"Cornea"},{"issue":"10","key":"10.1016\/j.ajo.2026.09.019_bib0076","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1097\/ICO.0000000000002642","article-title":"A close look at the clinical efficacy of rho-associated protein kinase inhibitor eye drops for Fuchs endothelial corneal dystrophy","volume":"40","author":"Kinoshita","year":"2021","journal-title":"Cornea"},{"key":"10.1016\/j.ajo.2026.09.019_bib0077","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ajo.2020.12.006","article-title":"Potential functional restoration of corneal endothelial cells in Fuchs endothelial corneal dystrophy by ROCK inhibitor (Ripasudil)","volume":"224","author":"Schl\u00f6tzer-Schrehardt","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2026.09.019_bib0078","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ajo.2026.06.014","article-title":"Descemet stripping only in Fuchs endothelial corneal dystrophy: results of a randomized clinical trial of topical Ripasudil and directions for future innovation","volume":"290","author":"Colby","year":"2026","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2026.09.019_bib0079","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1167\/iovs.12-11320","article-title":"The ROCK inhibitor eye drop accelerates corneal endothelium wound healing","volume":"54","author":"Okumura","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"15","key":"10.1016\/j.ajo.2026.09.019_bib0080","doi-asserted-by":"crossref","first-page":"5572","DOI":"10.3390\/jcm14155572","article-title":"Clinical evaluation of Ripasudil for corneal edema: a large-scale retrospective cohort study","volume":"14","author":"Erdinest","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.ajo.2026.09.019_bib0081","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ajo.2021.03.006","article-title":"Randomized, double-masked, pilot study of Netarsudil 0.02% ophthalmic solution for treatment of corneal edema in Fuchs dystrophy","volume":"227","author":"Price","year":"2021","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2026.09.019_bib0082","doi-asserted-by":"crossref","DOI":"10.1167\/tvst.10.4.18","article-title":"The ROCK inhibitor Ripasudil shows an endothelial protective effect in patients with low corneal endothelial cell density after cataract surgery","volume":"10","author":"Fujimoto","year":"2021","journal-title":"Transl Vis Sci Technol"},{"issue":"6","key":"10.1016\/j.ajo.2026.09.019_bib0083","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1007\/s40123-024-00950-x","article-title":"The protective effect of rho-associated kinase inhibitor eye drops (Ripasudil) on corneal endothelial cells after cataract surgery: a prospective comparative study","volume":"13","author":"Alkharashi","year":"2024","journal-title":"Ophthalmol Ther"},{"issue":"7","key":"10.1016\/j.ajo.2026.09.019_bib0084","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1097\/ICO.0000000000003827","article-title":"Efficacy of the Rho-Kinase inhibitor for corneal endothelial protection in Fuchs endothelial corneal dystrophy after phacoemulsification","volume":"44","author":"Keeratidamkerngsakul","year":"2025","journal-title":"Cornea"},{"issue":"6","key":"10.1016\/j.ajo.2026.09.019_bib0085","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1177\/11206721251351154","article-title":"Rock-inhibitors eyedrops preventing cataract surgery induced corneal failure in Fuchs corneal dystrophy","volume":"35","author":"Gaudenzi","year":"2025","journal-title":"Eur J Ophthalmol"},{"issue":"9","key":"10.1016\/j.ajo.2026.09.019_bib0086","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1097\/ICO.0000000000002975","article-title":"Surgical management of Fuchs endothelial corneal dystrophy: a treatment algorithm and individual patient meta-analysis of descemet stripping only","volume":"41","author":"Din","year":"2022","journal-title":"Cornea"},{"issue":"5","key":"10.1016\/j.ajo.2026.09.019_bib0087","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/ICO.0000000000001883","article-title":"Use of topical rho kinase inhibitors in the treatment of Fuchs dystrophy after descemet stripping only","volume":"38","author":"Macsai","year":"2019","journal-title":"Cornea"},{"issue":"6","key":"10.1016\/j.ajo.2026.09.019_bib0088","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/ICO.0000000000001209","article-title":"Descemetorhexis without grafting for Fuchs endothelial dystrophy-supplementation with topical ripasudil","volume":"36","author":"Moloney","year":"2017","journal-title":"Cornea"},{"issue":"3","key":"10.1016\/j.ajo.2026.09.019_bib0089","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/ICO.0000000000002437","article-title":"Descemet stripping only supplemented with topical ripasudil for Fuchs endothelial dystrophy 12-month outcomes of the Sydney eye hospital study","volume":"40","author":"Moloney","year":"2021","journal-title":"Cornea"},{"key":"10.1016\/j.ajo.2026.09.019_bib0090","doi-asserted-by":"crossref","unstructured":"Ploysangam P, Patel SP. A case report illustrating the postoperative course of descemetorhexis without endothelial keratoplasty with topical netarsudil therapy. Case Rep Ophthalmol Med. 2019;2019(1):6139026. doi:10.1155\/2019\/6139026.","DOI":"10.1155\/2019\/6139026"},{"issue":"4","key":"10.1016\/j.ajo.2026.09.019_bib0091","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/j.jcrs.0000000000000115","article-title":"Effect of rho-associated kinase inhibitor on human corneal endothelial cell apoptosis","volume":"46","author":"Achiron","year":"2020","journal-title":"J Cataract Refract Surg"},{"issue":"8","key":"10.1016\/j.ajo.2026.09.019_bib0092","first-page":"1566","article-title":"Expression of cell cycle-associated proteins in human and rabbit corneal endothelium in Situ","volume":"37","author":"Joyce","year":"1996","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"10.1016\/j.ajo.2026.09.019_bib0093","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1074\/jbc.RA117.000295","article-title":"Fibroblast growth factor 2 induces proliferation and fibrosis via SNAI1-mediated activation of CDK2 and ZEB1 in corneal endothelium","volume":"293","author":"Lee","year":"2018","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.ajo.2026.09.019_bib0094","first-page":"2252","article-title":"Distribution and putative roles of fibroblast growth factor-2 isoforms in corneal endothelial modulation","volume":"39","author":"Gu","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"10.1016\/j.ajo.2026.09.019_bib0095","first-page":"2326","article-title":"Fibroblast growth factor 2 uses distinct signaling pathways for cell proliferation and cell shape changes in corneal endothelial cells","volume":"37","author":"Gu","year":"1996","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.ajo.2026.09.019_bib0096","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0014-4835(87)80097-0","article-title":"Regeneration of cat corneal endothelium induced in vivo by fibroblast growth factor","volume":"45","author":"Landshman","year":"1987","journal-title":"Exp Eye Res"},{"issue":"6","key":"10.1016\/j.ajo.2026.09.019_bib0097","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1006\/exer.2000.0918","article-title":"The role of endogenous growth factors to support corneal endothelial migration after wounding in vitro","volume":"71","author":"Schilling-Sch\u00f6n","year":"2000","journal-title":"Exp Eye Res"},{"issue":"11","key":"10.1016\/j.ajo.2026.09.019_bib0098","doi-asserted-by":"crossref","first-page":"8216","DOI":"10.1167\/iovs.11-8213","article-title":"Human corneal endothelial cells employ phosphorylation of p27(Kip1) at both Ser10 and Thr187 Sites for FGF-2-mediated cell proliferation via PI 3-kinase","volume":"52","author":"Lee","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.ajo.2026.09.019_bib0099","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1167\/iovs.02-0637","article-title":"Regulatory role of PI 3-kinase on expression of Cdk4 and p27, nuclear localization of Cdk4, and phosphorylation of p27 in corneal endothelial cells","volume":"44","author":"Lee","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1-6","key":"10.1016\/j.ajo.2026.09.019_bib0100","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/08977194.2021.2012468","article-title":"Regenerative responses of rabbit corneal endothelial cells to stimulation by fibroblast growth factor 1 (FGF1) derivatives, TTHX1001 and TTHX1114","volume":"39","author":"Weant","year":"2021","journal-title":"Growth Factors"},{"issue":"12","key":"10.1016\/j.ajo.2026.09.019_bib0101","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.3109\/02713689208999541","article-title":"Human recombinant bFGF stimulates corneal endothelial wound healing in rabbits","volume":"11","author":"Rieck","year":"1992","journal-title":"Curr Eye Res"},{"issue":"185","key":"10.1016\/j.ajo.2026.09.019_bib0102","doi-asserted-by":"crossref","DOI":"10.3791\/63482","article-title":"A Human corneal organ culture model of Descemet\u2019s stripping only with accelerated healing stimulated by engineered fibroblast growth factor 1","volume":"2022","author":"Pizzuto","year":"2022","journal-title":"J Vis Exp"},{"issue":"2","key":"10.1016\/j.ajo.2026.09.019_bib0103","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/ICO.0000000000003098","article-title":"Acceleration of regeneration of the corneal endothelial layer after descemet stripping induced by the engineered FGF TTHX1114 in Human corneas in organ culture","volume":"42","author":"Pizzuto","year":"2023","journal-title":"Cornea"},{"key":"10.1016\/j.ajo.2026.09.019_bib0104","unstructured":"Study Details NCT04520321 | A phase 1\/phase 2 study of TTHX1114(NM141) | clinical trials. ClinicalTrials.gov. Accessed September 8, 2026. https:\/\/clinicaltrials.gov\/study\/NCT04520321."},{"key":"10.1016\/j.ajo.2026.09.019_bib0105","unstructured":"Study Details NCT04676737 | TTHX1114(NM141) in combination with DWEK\/DSO | clinical trials. ClinicalTrials.gov. Accessed September 8, 2026. https:\/\/clinicaltrials.gov\/study\/NCT04676737."},{"issue":"1","key":"10.1016\/j.ajo.2026.09.019_bib0106","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.exer.2011.08.003","article-title":"Endothelial mesenchymal transformation mediated by IL-1\u03b2-induced FGF-2 in corneal endothelial cells","volume":"95","author":"Lee","year":"2012","journal-title":"Exp Eye Res"},{"issue":"1","key":"10.1016\/j.ajo.2026.09.019_bib0107","first-page":"150","article-title":"Effects of platelet-derived growth factor on endothelial wound healing of human corneas","volume":"35","author":"Hoppenreijs","year":"1994","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.ajo.2026.09.019_bib0108","first-page":"1946","article-title":"Effects of human epidermal growth factor on endothelial wound healing of human corneas","volume":"33","author":"Hoppenreijs","year":"1992","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"10.1016\/j.ajo.2026.09.019_bib0109","first-page":"3292","article-title":"Effects of epidermal growth factor, fibroblast growth factor, and transforming growth factor-beta on corneal cell chemotaxis","volume":"33","author":"Grant","year":"1992","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"10.1016\/j.ajo.2026.09.019_bib0110","first-page":"2305","article-title":"Enhanced healing of cat corneal endothelial wounds by epidermal growth factor","volume":"34","author":"Raphael","year":"1993","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.ajo.2026.09.019_bib0111","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1167\/iovs.03-0814","article-title":"Proliferative response of corneal endothelial cells from young and older donors","volume":"45","author":"Zhu","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"10.1016\/j.ajo.2026.09.019_bib0112","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.2353\/ajpath.2010.100279","article-title":"Evidence of oxidative stress in the pathogenesis of Fuchs endothelial corneal dystrophy","volume":"177","author":"Jurkunas","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajo.2026.09.019_bib0113","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.freeradbiomed.2017.12.036","article-title":"NQO1 downregulation potentiates menadione-induced endothelial-mesenchymal transition during rosette formation in fuchs endothelial corneal dystrophy","volume":"116","author":"Katikireddy","year":"2017","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.ajo.2026.09.019_bib0114","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.exer.2014.06.002","article-title":"N-acetylcysteine increases corneal endothelial cell survival in a mouse model of Fuchs endothelial corneal dystrophy","volume":"127","author":"Kim","year":"2014","journal-title":"Exp Eye Res"},{"issue":"2","key":"10.1016\/j.ajo.2026.09.019_bib0115","doi-asserted-by":"crossref","DOI":"10.4161\/cbt.9.2.10583","article-title":"N-acetylcysteine, reactive oxygen species and beyond","volume":"9","author":"Sun","year":"2010","journal-title":"Cancer Biol Ther"},{"issue":"2","key":"10.1016\/j.ajo.2026.09.019_bib0116","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.survophthal.2021.07.008","article-title":"The role of topical n-acetylcysteine in ocular therapeutics","volume":"67","author":"Eghtedari","year":"2022","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2026.09.019_bib0117","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1073\/pnas.1912546116","article-title":"Ultraviolet A light induces DNA damage and estrogen-DNA adducts in fuchs endothelial corneal dystrophy causing females to be more affected","volume":"117","author":"Liu","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.ajo.2026.09.019_bib0118","first-page":"1356","article-title":"N-acetylcysteine alleviates progression of Fuchs endothelial corneal dystrophy in a UVA irradiation-induced mouse model","volume":"59","author":"Liu","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2026.09.019_bib0119","unstructured":"Study Details NCT04440280 | Targeting reactive oxygen species production as a novel therapeutic in Fuch\u2019s endothelial corneal dystrophy | clinical trials. ClinicalTrials.gov. Accessed September 8, 2026. https:\/\/clinicaltrials.gov\/study\/NCT04440280."},{"issue":"1","key":"10.1016\/j.ajo.2026.09.019_bib0120","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-62602-x","article-title":"Chronology of cellular events related to mitochondrial burnout leading to cell death in Fuchs endothelial corneal dystrophy","volume":"10","author":"M\u00e9thot","year":"2020","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.ajo.2026.09.019_bib0121","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26030944","article-title":"Elamipretide: a review of its structure, mechanism of action, and therapeutic potential","volume":"26","author":"Tung","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajo.2026.09.019_bib0122","unstructured":"Study Details NCT02653391 | A study investigating the safety, tolerability, and efficacy of elamipretide topical ophthalmic solution for the treatment of Fuchs\u2019 Corneal endothelial dystrophy (FCED) | clinical trials. ClinicalTrials.gov. Accessed September 8, 2026. https:\/\/clinicaltrials.gov\/study\/NCT02653391."},{"issue":"1","key":"10.1016\/j.ajo.2026.09.019_bib0123","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41392-023-01608-z","article-title":"Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease","volume":"8","author":"Panwar","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"10.1016\/j.ajo.2026.09.019_bib0124","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ajo.2026.09.019_bib0125","first-page":"3406","article-title":"Rapamycin prevents endothelial cell migration by inhibiting the endothelial-to-mesenchymal transition and matrix metalloproteinase-2 and -9: an in vitro study","volume":"17","author":"Gao","year":"2011","journal-title":"Mol Vis"},{"issue":"12","key":"10.1016\/j.ajo.2026.09.019_bib0126","doi-asserted-by":"crossref","first-page":"7424","DOI":"10.1167\/iovs.13-12674","article-title":"Rapamycin inhibits the production of myofibroblasts and reduces corneal scarring after photorefractive keratectomy","volume":"54","author":"Milani","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2026.09.019_bib0127","unstructured":"Study Details NCT05376176 | A multicenter study assessing the efficacy and safety of STN1010904 ophthalmic suspension 0.03% and 0.1% compared with vehicle in subjects with Fuchs endothelial corneal dystrophy (FECD) | clinical trials. ClinicalTrials.gov. Accessed September 8, 2026. https:\/\/clinicaltrials.gov\/study\/NCT05376176."},{"key":"10.1016\/j.ajo.2026.09.019_bib0128","unstructured":"Santen Pharmaceutical Co., Ltd. FY2025 Financial results. May 12, 2026. Accessed September 8, 2026. https:\/\/www.santen.com\/content\/dam\/santen\/global\/pdf\/en\/ir\/document\/202603\/mtg2026.pdf."},{"issue":"10","key":"10.1016\/j.ajo.2026.09.019_bib0129","doi-asserted-by":"crossref","first-page":"6724","DOI":"10.1167\/iovs.13-12699","article-title":"Sulforaphane decreases endothelial cell apoptosis in Fuchs endothelial corneal dystrophy: a novel treatment","volume":"54","author":"Ziaei","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"10.1016\/j.ajo.2026.09.019_bib0130","doi-asserted-by":"crossref","first-page":"5806","DOI":"10.1167\/iovs.12-10119","article-title":"Decline in DJ-1 and decreased nuclear translocation of Nrf2 in Fuchs endothelial corneal dystrophy","volume":"53","author":"Bitar","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2026.09.019_bib0131","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101763","article-title":"Nrf2: a unifying transcription factor in the pathogenesis of Fuchs\u2019 endothelial corneal dystrophy","volume":"37","author":"Lovatt","year":"2020","journal-title":"Redox Biol"},{"issue":"2","key":"10.1016\/j.ajo.2026.09.019_bib0132","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/bbrc.1997.6943","article-title":"An Nrf2\/Small Maf heterodimer mediates the induction of phase ii detoxifying enzyme genes through antioxidant response elements","volume":"236","author":"Itoh","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ajo.2026.09.019_bib0133","doi-asserted-by":"crossref","DOI":"10.1016\/j.coph.2023.102429","article-title":"Targeting the NRF2 pathway: a promising approach for corneal endothelial dysfunction","volume":"74","author":"Ward","year":"2024","journal-title":"Curr Opin Pharmacol"},{"issue":"2","key":"10.1016\/j.ajo.2026.09.019_bib0134","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1089\/ars.2017.7269","article-title":"Role of nicotinamide adenine dinucleotide and related precursors as therapeutic targets for age-related degenerative diseases: rationale, biochemistry, pharmacokinetics, and outcomes","volume":"30","author":"Braidy","year":"2018","journal-title":"Antioxid Redox Signal"},{"issue":"4","key":"10.1016\/j.ajo.2026.09.019_bib0135","doi-asserted-by":"crossref","DOI":"10.1152\/ajpcell.00445.2019","article-title":"NAD+ precursors protect corneal endothelial cells from UVB-induced apoptosis","volume":"318","author":"Zhao","year":"2020","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.ajo.2026.09.019_bib0136","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.exer.2019.04.012","article-title":"Nicotinamide inhibits corneal endothelial mesenchymal transition and accelerates wound healing","volume":"184","author":"Li","year":"2019","journal-title":"Exp Eye Res"},{"issue":"1","key":"10.1016\/j.ajo.2026.09.019_bib0137","doi-asserted-by":"crossref","DOI":"10.1172\/JCI146658","article-title":"Long-term corneal recovery by simultaneous delivery of hPSC-derived corneal endothelial precursors and nicotinamide","volume":"132","author":"Li","year":"2022","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.ajo.2026.09.019_bib0138","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/hmg\/ddr473","article-title":"An alpha 2 collagen VIII transgenic knock-in mouse model of Fuchs endothelial corneal dystrophy shows early endothelial cell unfolded protein response and apoptosis","volume":"21","author":"Jun","year":"2012","journal-title":"Hum Mol Genet"},{"issue":"2","key":"10.1016\/j.ajo.2026.09.019_bib0139","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ajo.2009.09.009","article-title":"Unfolded protein response in Fuchs endothelial corneal dystrophy: a unifying pathogenic pathway?","volume":"149","author":"Engler","year":"2010","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2026.09.019_bib0140","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1167\/iovs.16-20147","article-title":"Screening and characterization of drugs that protect corneal endothelial cells against unfolded protein response and oxidative stress","volume":"58","author":"Kim","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"10.1016\/j.ajo.2026.09.019_bib0141","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.18632\/aging.101659","article-title":"TGF-\u03b2 induces corneal endothelial senescence via increase of mitochondrial reactive oxygen species in chronic corneal allograft failure","volume":"10","author":"Li","year":"2018","journal-title":"Aging"},{"issue":"14","key":"10.1016\/j.ajo.2026.09.019_bib0142","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26146685","article-title":"TGF-\u03b2 promotes endothelial-to-mesenchymal transition and alters corneal endothelial cell migration in Fuchs endothelial corneal dystrophy","volume":"26","author":"Yan","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.ajo.2026.09.019_bib0143","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-06924-3","article-title":"Activation of TGF-\u03b2 signaling induces cell death via the unfolded protein response in Fuchs endothelial corneal dystrophy","volume":"7","author":"Okumura","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajo.2026.09.019_bib0144","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2025.110334","article-title":"Involvement of TGF-\u03b2 signaling pathway-associated genes in the corneal endothelium of patients with Fuchs endothelial corneal dystrophy","volume":"255","author":"Nakagawa","year":"2025","journal-title":"Exp Eye Res"},{"issue":"12","key":"10.1016\/j.ajo.2026.09.019_bib0145","doi-asserted-by":"crossref","DOI":"10.3390\/cells12121624","article-title":"Investigating the role of TGF-\u03b2 signaling pathways in human corneal endothelial cell primary culture","volume":"12","author":"Aouimeur","year":"2023","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.ajo.2026.09.019_bib0146","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0058000","article-title":"Inhibition of TGF-\u03b2 signaling enables human corneal endothelial cell expansion in vitro for use in regenerative medicine","volume":"8","author":"Okumura","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ajo.2026.09.019_bib0147","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1159\/000494480","article-title":"LY2109761, transforming growth factor \u03b2 receptor type I and type II dual inhibitor, Is a novel approach to suppress endothelial mesenchymal transformation in Human corneal endothelial cells","volume":"50","author":"Zhang","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.ajo.2026.09.019_bib0148","unstructured":"Sumioka T, Ikeda K, Okada Y, Yamanaka O, Kitano A, Saika S. Inhibitory effect of blocking TGF-\u03b2\/smad signal on injury-induced fibrosis of corneal endothelium. Mol Vis. 2008;14:2272-2281. Accessed September 8, 2026. http:\/\/resolver.scholarsportal.info\/resolve\/10900535\/v14inone\/2272_ieobtsoifoce.xml."},{"issue":"2","key":"10.1016\/j.ajo.2026.09.019_bib0149","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ajpath.2021.10.016","article-title":"The neuropeptide alpha-melanocyte\u2013stimulating hormone is critical for corneal endothelial cell protection and graft survival after transplantation","volume":"192","author":"Lu\u017enik Marzidov\u0161ek","year":"2022","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajo.2026.09.019_bib0150","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1749-6632.2000.tb05389.x","article-title":"Neuropeptide regulation of immunity: the immunosuppressive activity of alpha-melanocyte-stimulating hormone (\u03b1-MSH)","volume":"917","author":"Taylor","year":"2000","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"10.1016\/j.ajo.2026.09.019_bib0151","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3109\/09273948.2015.1092560","article-title":"The role of alpha-MSH as a modulator of ocular immunobiology exemplifies mechanistic differences between melanocortins and steroids","volume":"25","author":"Clemson","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.ajo.2026.09.019_bib0152","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-69416-1","article-title":"Neuropeptide alpha-melanocyte stimulating hormone preserves corneal endothelial morphology in a murine model of Fuchs dystrophy","volume":"14","author":"Kahale","year":"2024","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ajo.2026.09.019_bib0153","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ajpath.2023.09.007","article-title":"The neuropeptide \u03b1-melanocyte\u2013Stimulating hormone prevents persistent corneal edema following injury","volume":"194","author":"Alemi","year":"2024","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajo.2026.09.019_bib0154","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2025.110515","article-title":"Treatment of nitrogen mustard-induced Corneal Injury with Alpha-melanocyte Stimulating Hormone","volume":"258","author":"Kahale","year":"2025","journal-title":"Exp Eye Res"},{"issue":"11","key":"10.1016\/j.ajo.2026.09.019_bib0155","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1001\/jamaophthalmol.2020.3413","article-title":"Association of \u03b1-melanocyte\u2013Stimulating hormone with corneal endothelial cell survival during oxidative stress and inflammation-induced cell loss in donor tissue","volume":"138","author":"Lu\u017enik","year":"2020","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2026.09.019_bib0156","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/TP.0b013e3181ac11ea","article-title":"Local treatment with alpha-melanocyte stimulating hormone reduces corneal allorejection","volume":"88","author":"Hamrah","year":"2009","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.ajo.2026.09.019_bib0157","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1186\/s12967-025-07458-3","article-title":"Therapeutic potential of curcumin in ophthalmic diseases: mechanisms and clinical applications","volume":"23","author":"Wang","year":"2025","journal-title":"J Transl Med"},{"issue":"3","key":"10.1016\/j.ajo.2026.09.019_bib0158","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3390\/molecules30030457","article-title":"Curcumin in ophthalmology: mechanisms, challenges, and emerging opportunities","volume":"30","author":"Ribeiro","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.ajo.2026.09.019_bib0159","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2025.110584","article-title":"Effects of curcumin-liposome formulation on inflammatory cascade activated by oxidative stress in primary human corneal epithelial cells","volume":"260","author":"Roszkowska","year":"2025","journal-title":"Exp Eye Res"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939426005337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939426005337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T09:05:42Z","timestamp":1794301542000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939426005337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":159,"alternative-id":["S0002939426005337"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2026.09.019","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regeneration and Replacement of the Corneal Endothelium: Advances in Cell Therapy, Tissue Engineering, Molecular and Pharmacologic Strategies","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2026.09.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}